ACE and atrial fibrillation: For patients with HFrEF and concurrent AF, therapies such as beta-blockers, angiotensin receptor inhibitor neprilysin (ARNI), angiotensin-converting enzyme inhibitors (ACEis), and sodium glucose cotransporter type 2 inhibitors (SGLT2is) are recommended to improve prognosis irrespective of AF status.